SEC target Bordynuik denies overstating JBI's

New Post Public Reply Private Reply Replies (0) Message Board
lucyinthesky

SEC target Bordynuik denies overstating JBI's assets

2012-04-10 13:43 ET - Street Wire

Also Street Wire (U-*SEC) U.S. Securities and Exchange Commission
Also Street Wire (U-JBII) JBI Inc

by Mike Caswell

John Bordynuik, the Ontario man facing civil charges from the U.S. Securities and Exchange Commission for overstating the assets of his pink sheets company by $9.99-million, denies that he did anything wrong. (All figures are in U.S. dollars.) He says that the $9.99-million was a credit for print and radio ads the company had bought, and he was told that the credit was worth that much.

The SEC claims that the overstatement occurred in 2009, in the third quarter and annual financials for JBI Inc., a pink sheets listing based in Ontario. The company's only substantial asset at the time was a set of prepaid print and radio ads JBI had acquired for one million shares. Despite recommendations of his accountant to value the ads conservatively, Mr. Bordynuik had them recorded on the company's balance sheet at a value of $9.99-million. The company later wrote the media credit down to nil without giving any substantial reason. The writedown came after the company had raised $8.4-million relying in part on the inflated assets, the SEC said.

In his response to the suit, Mr. Bordynuik says that he bought the credit from another public company, Domark International, which had valued the advertising in past SEC filings at $10-million. He admits that JBI only issued $1-million worth of stock to buy the credit, but says he received assurances from Domark's chief executive officer that the credit was worth $9.99-million and that the valuation had been "cleared with the SEC."

SEC's complaint

The case began on Jan. 4, 2012, when the SEC filed a civil fraud complaint against Mr. Bordynuik in the District of Massachusetts, where JBI once had an office. It listed Mr. Bordynuik, 41, as a resident of Niagara Falls, Ont., and as the CEO of JBI. The other defendants were JBI itself and the company's former chief financial officer, Robert Baldwin of Florida.

The problems with the company's balance sheet, as described by the SEC, came about after Mr. Bordynuik acquired majority control of a shell that would become JBI in April, 2009. The company's primary product was a process that it claimed could convert discarded plastic into oil. In August, 2009, JBI purchased the media credits, issuing one million shares at $1.

The first time that the company had to report the credits was in its third quarter results for 2009. According to the SEC, Mr. Bordynuik told his accountant that he needed the credits to show as a substantial asset. His instructions, recorded in a Skype conversation, were to "get the pro formas as juicy as you can so I can acquire a chemical company for less." The accountant had some reservations, telling him that it would be better to value the credits at the $1-million that the company had paid for them. Despite the advice, Mr. Bordynuik persisted in having the ads listed at the $9.99-million value, the SEC said.

According to the complaint, JBI continued to state the inflated asset values as the company was raising money. Between the fall of 2009 and May, 2010, JBI raised $8.4-million relying in part on materials that represented the company's financial position as including the media credit. The inclusion of the credit presented a "misleadingly strong financial picture" of JBI, the complaint stated. (The company ultimately wrote the credit down to nil, only stating that its previously issued financial results should not be relied upon.)

The SEC also accused Mr. Bordynuik of having an inappropriate level of influence on JBI's auditor, Florida firm Gately & Associates. On Nov. 28, 2009, just months before JBI's year-end financial results were due, the principal of Gately was arrested for violation of probation, drinking and driving, and possession of marijuana. The SEC said that after Mr. Bordynuik learned of the arrest he agreed to pay for a criminal lawyer to defend the auditor and to pay for an alcohol treatment program. This dissolved any notion of independence, according to the complaint.

The SEC said there was also no evidence that anyone at Gately did a proper audit of JBI's annual financials, which included the media credit. No one at JBI was able to contact the auditor for a significant period of time before the company's year-end filing. Despite this, an employee at Gately applied the firm's electronic signature to JBI's Form 10-K, falsely representing that there had been an audit, the SEC claimed.

The complaint sought disgorgement of ill-gotten gains, appropriate civil penalties, and officer and director bans for Mr. Bordynuik and Mr. Baldwin.

Bordynuik denies any wrongdoing

In his answer to the complaint, filed on April 5, Mr. Bordynuik denies that he did anything wrong. He says JBI recorded the media credit using the same methods and reasons that Domark had used in its SEC filings, in which it valued the credit at $10-million. JBI also hired the same bookkeeper who had prepared Domark's financial statements.

According to the answer, Mr. Bordynuik did not instruct JBI's accountant to artificially boost the company's assets. He says the Skype conversation the SEC quoted in its complaint was taken out of context. Moreover, the accountant testified under oath that Mr. Bordynuik had never asked her to "plug numbers" or inflate the balance sheet.

Mr. Bordynuik further denies having any improper influence over JBI's auditor. He says he learned just before Christmas in 2009 that the principal of Gately & Associates had been jailed on alcohol-related issues, but denies that he paid for a defence lawyer. He acknowledges that JBI paid fees to Gately, which may have been used to pay for criminal representation. A colleague of Gately's principal performed audit work on behalf of Gately while the principal was unavailable.

Mr. Bordynuik asks that the court dismiss the case, with costs. The answer was filed by Juan Marcelino of Greenberg Traurig LLP on behalf of both Mr. Bordynuik and JBI. Mr. Marcelino also filed a separate but very similar answer on behalf of Mr. Baldwin. He too denies any wrongdoing, and asks that the case be dismissed.

JBI, which has been as high as $7.45 in the past three years, last traded at $1.20.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 202

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 37

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 400

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 570

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 142

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 607

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 16

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Latest Position Disclosure by Rathbones Group

Updated Category News Views 129

Understanding the Latest Position Disclosure by Rathbones Group In the competitive landscape of the financial market, the need for transparency has never been more critical, especially when it comes to securities that hold substantial stakes. Today, we delve into the recent disclosure made by Rathbones Group Plc regarding their position in Primary Health Properties Plc....

Continue Reading
Stride, Inc. Faces Major Concerns Following Platform Issues

Updated Category News Views 493

Stride, Inc. Experiences Significant Challenges Recent events have revealed substantial challenges for Stride, Inc. (NYSE: LRN), a company known for its online education platform. Following a significant operational issue stemming from a platform upgrade, the company’s stock has witnessed a dramatic decline, which has drawn the attention of investors and watchdogs...

Continue Reading
MoEngage Achieves Customers' Choice Recognition in 2025

Updated Category News Views 162

MoEngage Recognized as a Customers' Choice for Email Marketing MoEngage, a leader in customer engagement solutions, is thrilled to share its recognition as the only vendor to be named a Customers' Choice in the 2025 Gartner Peer Insights™ Voice of the Customer for Email Marketing report. Achieving an exceptional 97% "Willingness to Recommend" score, MoEngage stands out...

Continue Reading
Organon & Co. Faces Class Action Over Shareholder Losses

Updated Category News Views 212

Class Action Lawsuit Against Organon & Co. Investors may have an opportunity to lead a class action lawsuit against Organon & Co. This follows allegations that the company made misleading statements that adversely affected its stock performance. For those concerned about their investments, this could be a significant moment. Understanding the Class Definition The class...

Continue Reading
Exploring NVIDIA's Options Trading Insights and Trends

Updated Category News Views 86

NVIDIA's Strategic Options Trading In the world of financial investments, NVIDIA has captured significant attention from market giants through its recent options trading patterns. A thorough analysis of trading activities for NVIDIA (NASDAQ: NVDA) reveals not only an increase in volume but also a notable inclination among traders indicating bullish sentiments....

Continue Reading